Answers are grounded in this paper and cite their sources.
This study confirms that NGS 176 is a useful first-tier genetic test for most IRD patients. Age and initial clinical diagnosis were strongly associated with diagnostic yield.
No takes yet. Share an insight, caveat, or question.
Sheck et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: